Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from India.
Patel A, Batra U, Prasad KT, Dabkara D, Ghosh J, Sharma M, Singh N, Suresh P, Jain P, Malik PS, Choudhary P, Ganguly S, Khurana S, Ms S, Bothra S, Muthu V, Biswas B.
Patel A, et al. Among authors: ms s.
Curr Probl Cancer. 2020 Jun;44(3):100571. doi: 10.1016/j.currproblcancer.2020.100571. Epub 2020 Mar 17.
Curr Probl Cancer. 2020.
PMID: 32234264
METHODS: This is a multi-center study in 5 major tertiary care cancer centers across India treating ALK-rearranged NSCLC patients from April 2013 to April 2019. ...ALK was evaluated by immunohistochemistry in majority of patients (97%), 3 patients by FISH and 3 more …
METHODS: This is a multi-center study in 5 major tertiary care cancer centers across India treating ALK-rearranged NSCLC patients fro …